Investigation of multiple mechanisms for potentiation of malaoxon's anticholinesterase action by triorthotolyl phosphate.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000032:analysis / Q000097:blood; D003408:Cresols / Q000008:administration & dosage / Q000494:pharmacology*; D004357:Drug Synergism; D004950:Esterases / Q000032:analysis / Q000037:antagonists & inhibitors / Q000097:blood; D007274:Injections, Intraperitoneal; D008099:Liver / Q000201:enzymology; D008168:Lung / Q000201:enzymology; D008294:Malathion / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D051379:Mice; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D003408:Cresols; D009943:Organophosphorus Compounds; D004950:Esterases; D002802:Cholinesterases; D008294:Malathion